OB/GYN Clinical Alert (Vol. 32, No. 1) – May 1, 2015

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: May 2015

Valid through: May 2018

Target Audience

This activity is intended for the obstetrician and gynecologist.

Subjects

  • OnabotulinumtoxinA and the Bladder
  • Using Etonogestrel Implants and LNG-IUDs Past FDA-approved Duration
  • Intrauterine Insemination Outcomes Are Not Affected by Sperm Morphology Parameters
  • Diagnostic Concordance in Breast Biopsies
  • Low-lying Intrauterine Devices: To Remove or Not to Remove?

Objectives

  • Explain the latest data regarding diagnosis and treatment of various diseases affecting women
  • Discuss new data concerning prenatal care, neonatal health, and complications arising in pregnancy and the perinatal period
  • Discuss the advantages, disadvantages, and cost-effectiveness of new testing procedures in women

Credit Available

Physicians

  • Maximum of 2.25 AMA PRA Category 1 Credit(s)

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing

Authors

Chiara Ghetti, MD, Associate Professor, Obstetrics and Gynecology, Director of Female Pelvic Medicine and Reconstructive Surgery, Washington University School of Medicine, St. Louis, MO

Rebecca H. Allen, MD, MPH, Assistant Professor, Department of Obstetrics and Gynecology, Warren Alpert Medical School of Brown University, Women and Infants Hospital, Providence, RI

Michael A. Thomas, MD, Professor, Reproductive Endocrinology and Infertility; Director, Division of Reproductive Endocrinology and Infertility, University of Cincinnati College of Medicine

Jeffrey T. Jensen, MD, MPH, Leon Speroff Professor and Vice Chair for Research, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland

Editors

Medical Editor: Jeffrey T. Jensen, MD, MPH

AHC Media executive editor: Leslie G. Coplin

Managing editor: Leslie Hamlin

Financial Disclosure

Rebecca Allen, MD, reports she is a consultant for Actavis and Bayer and receives grant/research support from Bayer. Michael A. Thomas, MD reports no financial relationships relevant to this field of study. Chiara Ghetti, MD, reports no financial relationships relevant to this field of study.

OB/GYN Clinical Alert's Editor, Jeffrey T. Jensen, MD, MPH, is a consultant for, on the Advisory Boards of, and receives grant/research support from HRA Pharma, Bayer Healthcare, Merck, Agile Pharm, Population Council, AbbVie, Evofem and ContraMed; and is a consultant for Teva Pharmaceuticals and MicroChips.

Peer Reviewer Catherine LeClair, MD, Executive Editor Leslie G. Coplin, and Managing Editor Leslie Hamlin report no financial relationship to this field of study.

Copyright 2015, AHC Media. All rights reserved.